The 20-30% rate of recurrence after surgical resection of stage II colon cancer (CC) suggests inadequate nodal sampling and/or inadequately sensitive and specific histologic assessment. Preliminary findings from our sentinel node (SN) study (CA 90484) demonstrate a 23% rate of nodal micrometastases (MM) missed by conventional sampling and histologic assessment. Our goal is to standardize the pathologic and surgical evaluation of stage II CC by focused analysis of a minimum number of nodes. We hypothesize that use of immunohistochemistry (IHC) and multimarker quantitative real-time PCR (qRT) assay to examine at least 12 LNs (a number recently endorsed by the National Quality Forum) will detect clinically relevant MM missed by standard hematoxylin and eosin (H&E) assessment of fewer than 12 nodes. In collaboration with the United States Military Cancer Institute (USMCI) Clinical Trials Group, which recently reported a Phase III randomized trial of nodal staging in CC, we will conduct a multicenter prospective trial of focused staging in 300 patients whose resected stage II CC specimens contain at least 12 nodes that stain negative with H&E. IHC will be performed and reviewed by USMCI pathologists, qRT assays and transcriptional analysis will be performed by UCLA scientists. Because patients will not receive adjuvant chemotherapy, we will be able to determine whether nodal MM identified by IHC and/or qRT have an impact on disease-free survival. As a corollary to this trial, we will also perform a comprehensive transcript analysis of the primary tumor specimens;the long-term goal is to create a prognostic index based on the primary tumor and LNs. This index should be helpful in identifying candidates for adjuvant therapy.
Specific Aim I. To determine prospectively whether IHC and/or molecular (qRT) evidence of nodal MM in a specimen containing =12 H&E-negative LNs correlates with disease-free survival after resection of stage II CC.
Specific Aim II. To evaluate the prognostic significance of molecular biomarkers detected in the primary tumor from patients with stage II CC.
Using quality surgery, standardized pathology and sophisticated molecular assays this trial will provide important information in determining which patients with early colon cancer are cured by surgery alone and which patients may benefit from chemotherapy.
|O'Connor, Victoria; Kitagawa, Yuko; Stojadinovic, Alexander et al. (2014) Targeted lymph node assessment in gastrointestinal neoplasms. Curr Probl Surg 51:9-37|
|Stojadinovic, Alexander; Bilchik, Anton; Smith, David et al. (2013) Clinical decision support and individualized prediction of survival in colon cancer: bayesian belief network model. Ann Surg Oncol 20:161-74|
|Arena, Elizabeth A; Bilchik, Anton J (2013) What is the optimal means of staging colon cancer? Adv Surg 47:199-211|
|Short, Scott S; Stojadinovic, Alexander; Nissan, Aviram et al. (2012) Adjuvant treatment of early colon cancer with micrometastases: results of a national survey. J Surg Oncol 106:119-22|
|Steele, Scott R; Chen, Steven L; Stojadinovic, Alexander et al. (2011) The impact of age on quality measure adherence in colon cancer. J Am Coll Surg 213:95-103; discussion 104-5|
|Wasif, Nabil; Faries, Mark B; Saha, Sukamal et al. (2010) Predictors of occult nodal metastasis in colon cancer: results from a prospective multicenter trial. Surgery 147:352-7|
|Bilchik, Anton; Nissan, Aviram; Wainberg, Zev et al. (2010) Surgical quality and nodal ultrastaging is associated with long-term disease-free survival in early colorectal cancer: an analysis of 2 international multicenter prospective trials. Ann Surg 252:467-74; discussion 474-6|
|Wasif, Nabil; Bentrem, David J; Farrell, James J et al. (2010) Invasive intraductal papillary mucinous neoplasm versus sporadic pancreatic adenocarcinoma: a stage-matched comparison of outcomes. Cancer 116:3369-77|
|Bilchik, Anton J; Stojadinovic, Alexander; Wainberg, Zev et al. (2009) Targeted lymph node evaluation in colorectal cancer: a decade of progress! J Surg Oncol 99:273-4|
|Koyanagi, Kazuo; Bilchik, Anton J; Saha, Sukamal et al. (2008) Prognostic relevance of occult nodal micrometastases and circulating tumor cells in colorectal cancer in a prospective multicenter trial. Clin Cancer Res 14:7391-6|
Showing the most recent 10 out of 30 publications